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Introduction
Restoration of blood flow to an ischaemic organ is essen-
tial to prevent irreversible tissue injury. Reperfusion, 
however, results in a local and systemic inflammatory 
response that may augment tissue injury in excess of 
that produced by ischaemia alone.1 Cellular damage 
after reperfusion of previously viable ischaemic tissue is 
defined as ischaemia-reperfusion (IR) injury.1 IR of 
skeletal muscle leads to a production of reactive oxygen 
species (ROS) and pro-inflammatory cytokines, which 
not only affects the muscle, but may also cause remote 
organ injury.2–5 Antioxidant and/or cytokine-modulat-
ing therapies might, therefore, reduce morbidity.6,7
Clinical IR interventional studies are widely per-
formed in patients with elective ischaemia, e.g. ortho-
paedic tourniquet surgery6,8–10 or transplantations7,11 or 
in acute ischaemia, e.g. acute myocardial infarction.12 
The studies apply a variety of interventions, such as 
antioxidative treatment (N-acetyl cysteine, vitamin C), 
ischaemic preconditioning, anaesthetic intervention 
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Abstract
Objective: Ischaemia-reperfusion (IR) injury is partly caused by the release of reactive oxygen species and cytokines and 
may result in remote organ injury. Surgical patients are exposed to surgical stress and anaesthesia, both of which can 
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potential of antioxidant and cytokine-modulatory treatments.
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Results: We found no significant increase in MDA in the muscle biopsies after reperfusion. Plasma levels of oxidative and 
pro- and anti-inflammatory parameters showed no significant differences between baseline and after reperfusion at any 
sampling time.
Conclusion: Twenty minutes of lower limb ischaemia does not result in an ischaemia-reperfusion injury in healthy 
volunteers, measurable by oxidative and pro- and anti-inflammatory biomarkers in muscle biopsies and in the systemic 
circulation.
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(propofol, ketamine, dexmedetomidine) and inflamma-
tion-modulating therapy (recombinant P-selectin glyco-
protein ligand IgG) and report of both non-significant10,11 
and beneficial effects6–9,12 of these interventions in 
reducing markers of oxidative stress and inflammation. 
However, the results of the reperfusion protective effect 
are difficult to interpret because of the added complex-
ity of the clinical situation, e.g. surgical stress and influ-
ence of anaesthesia and a simple experimental model 
without these interfering factors is, therefore, warranted.
The time frame for enduring ischaemia is somewhere 
between 20 and 30 minutes if the subjects are to com-
plete the study without the need of anaesthetics and 
analgesics.13
In this study, we investigated if 20 minutes of ischae-
mia of the lower extremity and 90 minutes of subse-
quent reperfusion was sufficient for the expression of 
biochemical markers of oxidative and inflammatory 
stress, both locally and in the systemic circulation.
Materials and Methods
The study protocol was approved by the local ethics 
committee (H-4-2011-110) and The Danish Data 
Protection Agency. All participants gave written 
informed consent before enrolment in the study. The 
trial was registered at www.clinicaltrials.gov 
(NCT01486212).
Study design
The study was a methodological study, including healthy 
subjects between the ages of 18 and 40. The trial con-
sisted of one study day. The subjects served as their own 
controls.
Exclusion criteria were: smoking, known vascular 
disease, known hypertension, known metabolic dis-
eases, known cardiovascular risk factors (familiar 
ischaemic heart disease, elevated total cholesterol, ele-
vated triglyceride, body mass index (BMI) >30, daily 
alcohol intake >5 units), intake of prescription medicine 
or ‘over-the-counter’ drugs <3 weeks prior to study par-
ticipation, infection treated with antibiotics <2 weeks 
before study participation or if no informed written 
consent was obtained.
The subjects were placed in a supine position in 
peaceful surroundings and relaxed for 20 minutes before 
the measurement of baseline blood pressure (BP) and 
heart rate (HR). An intravenous catheter was inserted 
into the cubital vein for blood sampling.
A baseline muscle biopsy was taken from the vastus 
lateralis muscle, approximately 10-15 cm above the 
patella. The biopsy was taken with a 5 mm Bergström 
muscle biopsy needle (Pelomi, Albertslund, Denmark).14 
A pneumatic tourniquet was placed on the opposite leg 
and inflated to a pressure of 300 mmHg and this pres-
sure was sustained for 20 minutes until deflation.
Before inflation (baseline), every fifth minute during 
inflation and until 15 minutes after deflation, the subject 
used a visual analogue scale (VAS) (0 mm = no pain, 100 
mm = maximal pain) to score pain (eight scores in 
total).
Blood samples were drawn at baseline and 5, 15, 30, 
60 and 90 minutes after reperfusion.
After 20 minutes of ischaemia, the pneumatic tourni-
quet was deflated (reperfusion). Thirty minutes after 
reperfusion, a muscle biopsy was taken from the vastus 
lateralis muscle just below the placing of the tourniquet.
Primary outcome
Malondialdehyde (MDA) in muscle biopsies. Immediately 
after the biopsies were taken, they were weighed and 
placed in cryo tubes. They were then frozen in liquid 
nitrogen and afterwards stored at -80° C until analysis. 
Tissues were homogenized in ice-cold phosphate 
buffered saline (1:10 weight/volume) and analyzed 
in triplicate for MDA with a SpectraMax Plus384  
UV-spectrophotometer (Molecular Devices, Sunnyvale, 
CA, USA) using the Morton-Stubb three-point correc-
tion as described previously.15
Secondary outcomes
Oxidative stress markers in blood samples. For the deter-
mination of the concentration of MDA, ascorbic acid 
(AA), dehydroascorbic acid (DHA) and total ascorbic 
acid (TAA) blood was drawn into tubes containing hep-
arin free of lipopolysaccharide (LPS) and centrifuged at 
3100 rpm for 3 minutes and then stored at -80° C until 
analysis. AA, DHA and TAA were stabilized with 10% 
meta-phosphoric acid containing 2 mM disodium eth-
ylenediaminetetraacetic acid (EDTA) before storage. 
Both MDA and AA were analyzed using high perfor-
mance liquid chromatograph (HPLC) methods as 
described previously.15,16
Inflammatory markers in blood samples. For the deter-
mination of pro- and anti-inflammatory cytokines 
and cytokine receptors and the pro-inflammatory 
marker YKL-40, blood was drawn into tubes contain-
ing EDTA and centrifuged at 3100 rpm for 3 minutes, 
then stored at -80° C until analysis. The cytokines 
tumor necrosis factor (TNF)-α, interleukin (IL)-1β, 
IL-1 receptor antagonist (IL-1Ra), IL-6, IL-10 and the 
soluble TNF receptors (sTNF-R) I and II were mea-
sured in a Luminex 100 IS analyser (Luminex Corpo-
ration, Austin, TX, USA), using appropriate multiplex 
antibody bead kits purchased from Invitrogen 
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(Invitrogen Corporation, Carlsbad, CA, USA). Data 
were analyzed using StarStation version 2.0 software 
(Applied Cytometry Systems, Sheffield, UK). The 
lowest levels of detection were (pg/ml): TNF-α: 0.5, 
IL-1β: 1.0, IL-1Ra: <100, IL-6: 1.0, IL-10: 1.0, TNF-RI: 
15 and TNF-RII: 15.
Kit precisions were (coefficient of variation (CV%)): 
TNF-α: 7.7, IL-1β: 4.4, IL-1Ra: 5.0, IL-6: 7.6, IL-10: 9.4, 
TNF-RI: 4.3 and TNF-RII: 7.9.
The concentration of YKL-40 in plasma was deter-
mined by a sandwich enzyme-linked immunosorbent 
assay (ELISA) (Quidel, Santa Clara, CA, USA) as 
described previously.17
Sample size
There are, to our knowledge, no other studies which 
have been performed with the same set-up and no pilot 
study was performed. Thus, our study population was 
based on a study in patients undergoing reconstruction 
of the ligamentum cruciatum genus anterior.18 In this 
study, they used 10 patients and found a significant 
increase in MDA 20 minutes after reperfusion, follow-
ing a tourniquet time of about 60 minutes.
Statistics
Data were analyzed using non-parametric methods, 
with Friedman analysis of variance and Wilcoxon´s 
signed ranks test. Data are presented as median (inter-
quartile range, IQR) unless specified otherwise. Results 
with p-values <0.05 were considered statistically signifi-
cant. Data were analyzed using SPSS version 20 software 
(SPSS, Chicago, IL, USA).
Results
Ten healthy young men were included in the study, with 
a median age of 24 years (range 22-39) and BMI 21 kg/m2 
(range 19-27). All participants completed the study with 
no missing samples.
Primary outcome
Malondialdehyde (MDA) in muscle biopsies. The weight 
of the muscle biopsies was 54.5 (18.5-95.8) mg at 
baseline and 73.5 (36.5-117.5) mg after reperfusion 
(p = 0.037).
The 20 minutes of ischaemia induced no signifi-
cant difference between MDA values when compar-
ing baseline 46.9 (38.8-50.8) nmol/g tissue with 30 
minutes of reperfusion 40.1 (31.4-48.0) (p>0.05) 
(Figure 1).
Secondary outcomes
Oxidative markers in plasma. None of the oxidative 
markers, MDA, AA or DHA, changed significantly 
from baseline to after reperfusion (p>0.05) (Figure 2).
Inflammatory markers in plasma. None of the pro- or 
anti-inflammatory cytokines or soluble cytokine recep-
tors (TNF-α, IL-1β, IL-1Ra, IL-6, IL-10, sTNF-RI and 
sTNF-RII) showed significant changes from baseline to 
90 minutes of reperfusion (p>0.05) (Figure 3).
The pro-inflammatory marker YKL-40 showed no 
significant difference from baseline to after reperfusion 
at any sampling time (p>0.05) (Figure 3).
Visual analogue scale (VAS) pain scores. There were sig-
nificant differences between pain scores, measured by 
VAS, at baseline value compared with 5, 10, 15 and 20 
minutes after inflation (p=0.005) and also 5 minutes 
after reperfusion (p=0.008).
There were no significant differences in pain scores, 
measured by VAS, between 5 and 20 minutes of ischae-
mia to the lower extremity (p=0.26). The peak VAS 
score was at 20 minutes of ischaemia, with a median of 
22 (10-56) mm (Figure 4). After 10 minutes of reperfu-
sion, there were no significant differences in VAS scores 
compared to baseline values (p>0.05).
Discussion
This study shows that 20 minutes of ischaemia of the 
lower limb did not produce a reperfusion injury that 
could be measured by a range of oxidative and inflam-
matory markers up to 90 minutes after reperfusion.
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Figure 1. Malondialdehyde (MDA) in muscle biopsies in each 
individual subject. No significant difference was found between 
baseline and 30 minutes after reperfusion (p>0.05). Data were 
analyzed using the Wilcoxon signed ranks test.
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Figure 3. Pro- and anti-inflammatory markers in plasma.
Column chart with median (top of column) and 75th percentiles (bars).
There were no significant differences in any of the investigated markers 
between baseline and post reperfusion (p>0.05). Data were analyzed 
using the Wilcoxon signed ranks test.
YKL-40 was analyzed using the Friedman analysis of variance.
IL-1β (interleukin-1β), IL-6 (interleukin-6), IL-10 (interleukin-10), TNF-
α (tumor necrosis factor alpha), IL-1Ra (interleukin-1Ra), sTNF-RI and 
II (soluble tumor necrosis factor receptors I and II). pg = picogram 
(10-12g). There were too few measurable amounts of TNF-α at baseline 
and after reperfusion and of IL-1Ra 90 minutes after reperfusion to 
express a median above 0.
Several studies using the pneumatic tourniquet dur-
ing surgery have documented the production of a sig-
nificantly increased amount of MDA in plasma 
(measured at 5 and 30 minutes after reperfusion and 
compared to baseline) as an expression of lipid peroxi-
dation by ROS.8,9,19,20 Several antioxidant interventions 
(vitamin C, N-acetyl cysteine and propofol) have been 
tested and proved to lower the MDA level.6,20,21 However, 
all these studies were performed in patients subjected to 
ischaemia for about 60 minutes, undergoing surgery 
and with the influence of different types of anaesthesia. 
It is known that several anaesthetic compounds, espe-
cially propofol, are powerful antioxidants, thus, making 
it difficult to distinguish the effect of the antioxidant 
intervention from the influence of anaesthesia in these 
models.9,19,22 Surgery elicits local as well as systemic 
inflammatory, endocrine/metabolic, humoral and 
immunological alterations which makes it difficult to 
interpret the results from interventional studies per-
formed in patients undergoing surgery.23–25 Hence, a 
simple model which excluded these influencing factors 
would be preferred for studies of IR-injuries.
In our study, we could not produce a reperfusion 
response upon which an intervention could be tested. 
This could be due to several reasons.
With regard to the oxidative markers, the ischaemic 
period (20 minutes) was probably too short for the pro-
duction of detectable amounts of MDA as an expression 
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Figure 2. Oxidative stress markers in plasma.
Box plot with median (black horizontal line), 25th and 75th percentiles 
(closed box) and ranges (bars) for oxidative stress markers in plasma. 
Malondialdehyde (MDA), ascorbic acid (AA), dehydroascorbic acid 
(DHA). BL = baseline. There were no significant differences in any of 
the oxidative markers between baseline and post reperfusion (p>0.05). 
Data were analyzed using the Friedman analysis of variance.
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of lipid peroxidation. For example, the duration of 
ischaemia-reperfusion is an important determinant of 
the degree of oxidative stress.26,27 Since we found no sig-
nificant difference in VAS pain scores between 5 and 20 
minutes, we could probably have continued the ischae-
mic period up to at least 30-35 minutes without the need 
of analgesics.13 Based on previous studies that have used 
a pneumatic tourniquet during surgery, this is probably 
a more realistic timeframe for the production of 
MDA.6,9,20,28 In these models, however, the surgical 
stress might also have contributed to the MDA 
response.29 Lipid peroxidation caused by IR of the 
extremities is one of the most important organic expres-
sions of oxidative stress induced by the reactivity of 
ROS.30 ROS and lipid peroxides are short-lived and dif-
ficult to measure directly. Thus, MDA, a more stable and 
longer living degradation product of lipid peroxides, is 
often used as reflecting the lipid peroxidation level.8,28,30 
The choice of MDA, as well as AA and DHA, as the oxi-
dative stress markers in plasma and the sampling times 
for these markers in our setup is in accordance with 
other studies.8 9,19,20,31
With regard to the pro- and anti-inflammatory mark-
ers, cytokines and cytokine receptors were measured 
at 90 minutes after reperfusion. We chose the pro-
inflammatory cytokines (IL-1β, IL-6 and TNF-α), 
anti-inflammatory cytokines (IL-10, IL-1Ra) and solu-
ble TNF-binding receptors (sTNF-RI and sTNF-RII) as 
the literature32,33 supports that these (IL-1 and TNF-α) 
are present at sites of local inflammation and their roles 
(IL-1, IL-6 and TNF- α) are well documented in IR inju-
ries.34 However, 90 minutes after reperfusion is probably 
not sufficient time to detect a response of reperfusion 
on cytokine production and release to the circulation. 
Indeed, other studies, measuring cytokines after tourni-
quet operations, have found a significantly increased 
level of the pro-inflammatory cytokine IL-6 between 4 
and 24 hours after reperfusion.3,35,36 TNF-α and IL-1 did 
not, however, increase significantly at this time. The 
tourniquet time in these studies was around 60-120 
minutes. An experimental study has shown that the 
highest response of TNF-α following severely injured 
post-ischaemic extremities was observed one minute 
after reperfusion and reached control levels after 10 
minutes of reperfusion.37 Thus, it might have been more 
appropriate if we had also analyzed the 5-minute blood 
sample, as we might have missed the TNF-α peak at this 
time-point.
In a surgical setting, IL-6 increased 30-60 minutes 
after commencing surgery and the change in concentra-
tion became significant after 2-4 hours.25 The degree of 
tissue trauma, i.e. 20 minutes of ischaemia, was proba-
bly also insufficient trauma to trigger an early cytokine 
response.38,39 Notably, the surgical stress in the tourni-
quet studies may, by itself, have contributed to the sys-
temic inflammatory response and these studies are not 
directly comparable to our setup, where we have avoided 
the influence of surgical stress.
In summary, the ischaemic period may have to be 
longer to provoke systemically detectable oxidative 
stress and cytokine responses and the post-reperfusion 
sampling times should be extended to measure a pro- 
and/or anti-inflammatory response in the circulation.
In our study, we measured the systemic response in 
blood taken from the antecubital vein contra-lateral to 
the reperfused leg. Some studies have shown that oxida-
tive stress markers measured at the site of the reperfu-
sion (local) are significantly increased compared to 
markers measured systemically.40,41 In our setup, obtain-
ing blood locally from the reperfused leg might have 
given a better response.
In conclusion, we were not able to show an effect of 
20 minutes ischaemia in our model and we, therefore, 
recommend that the setup for a future methodological 
study should include an ischaemic period of 30-35 min-
utes and post-reperfusion sampling times ranging from 
5 minutes up to a minimum of 4 hours after reperfusion. 
The proposed setup is still feasible without the use of 
anaesthetic supplement.
If the setup is successful in obtaining a detectable IR 
injury response, it could potentially be an interesting 
supplement in the aspect of testing antioxidant therapy 
upon IR injuries.
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